Late Breaking Abstract - Inhaled pirfenidone is associated with better quality of life scores in idiopathic pulmonary fibrosis
G. Kim (Los Angeles, United States), J. Goldin (Los Angeles, United States), F. Woodhead (Seattle, United States), C. Thompson (Seattle, United States), M. Shaffer (Seattle, United States), K. Otto (Seattle, United States), B. Montgomery (Seattle, United States)
Source: International Congress 2022 – How to prevent progression in idiopathic interstitial pneumonias
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Kim (Los Angeles, United States), J. Goldin (Los Angeles, United States), F. Woodhead (Seattle, United States), C. Thompson (Seattle, United States), M. Shaffer (Seattle, United States), K. Otto (Seattle, United States), B. Montgomery (Seattle, United States). Late Breaking Abstract - Inhaled pirfenidone is associated with better quality of life scores in idiopathic pulmonary fibrosis. 2670
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|